Prediction of Fraction Unbound in Human Plasma for Per- and Polyfluoroalkyl Substances: Evaluating Transfer Learning
Gabriel Sinclair1, Nathaniel Charest1, Barbara A Wetmore1
1Center for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27711, United States.
None:
Fraction unbound in plasma (Fup) is a crucial parameter in physiologically based toxicokinetic (PBTK) models, representing the fraction of a chemical compound that is not sequestered by plasma proteins when present in the bloodstream. This is often used as a proxy for the quantity of the compound that is bioavailable for metabolism or the exertion of physiological effects; on the other hand, a low Fup is also a predictor for bioaccumulative potential. In this work, we propose and investigate a new machine learning methodology to improve our quantitative structure-activity relationship (QSAR) modeling of Fup for specific chemical classes, including per- and polyfluoroalkyl substances (PFAS). We evaluate a novel transfer learning strategy across chemical space, using a deep learning model trained on a broad chemical library and fine-tuned on a small data set of PFAS, in terms of its added value compared to a global random forest model presented in a prior publication. Our results demonstrate increased statistical performance after the fine-tuning process when applied to other similarly small chemical families; however, due to the sparsity and imbalance of the data, the prior global model remains the most competitive for PFAS. We conclude our work with an investigation of the PFAS structural space in relation to the activity of interest, formulating recommendations for future experimental characterization to expand the knowledge space for modeling. The measurement of these data will inform our PFAS models and may ultimately produce sufficient data amenable to modeling to improve the viability of local and transfer learning approaches for this class of chemicals.
Related Concept Videos
Drug Distribution: Plasma Protein Binding
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Drug Concentrations: Measurements
Plasma...


